C126H224F3N45O — CID 157064007
1-tert-butyl-4-(1-methylpyrrolidin-2-yl)triazole;1-tert-butyl-4-[(2R)-1-methylpyrrolidin-2-yl]triazole;1-tert-butyl-4-pyrrolidin-2-ylimidazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-pyrrolidin-2-yltriazole;N-methyl-1-(2-methyl-1-propan-2-ylimidazol-4-yl)methanamine;N-methyl-1-(3-propan-2-yl-1,2-oxazol-5-yl)methanamine;N-methyl-1-(1-propan-2-yltriazol-4-yl)methanamine;N-methyl-1-[1-propan-2-yl-2-(trifluoromethyl)imidazol-4-yl]methanamine;4-[(2S)-1-methylpyrrolidin-2-yl]-1-propan-2-yltriazole;1-propan-2-yl-4-[(2R)-pyrrolidin-2-yl]triazole;1-propan-2-yl-4-[(2S)-pyrrolidin-2-yl]triazole (PubChem CID 157064007) has the molecular formula C126H224F3N45O and a molecular weight of 2442.49 g/mol. Its IUPAC name is 1-tert-butyl-4-(1-methylpyrrolidin-2-yl)triazole;1-tert-butyl-4-[(2R)-1-methylpyrrolidin-2-yl]triazole;1-tert-butyl-4-pyrrolidin-2-ylimidazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-pyrrolidin-2-yltriazole;N-methyl-1-(2-methyl-1-propan-2-ylimidazol-4-yl)methanamine;N-methyl-1-(3-propan-2-yl-1,2-oxazol-5-yl)methanamine;N-methyl-1-(1-propan-2-yltriazol-4-yl)methanamine;N-methyl-1-[1-propan-2-yl-2-(trifluoromethyl)imidazol-4-yl]methanamine;4-[(2S)-1-methylpyrrolidin-2-yl]-1-propan-2-yltriazole;1-propan-2-yl-4-[(2R)-pyrrolidin-2-yl]triazole;1-propan-2-yl-4-[(2S)-pyrrolidin-2-yl]triazole.
| Compound Name | 1-tert-butyl-4-(1-methylpyrrolidin-2-yl)triazole;1-tert-butyl-4-[(2R)-1-methylpyrrolidin-2-yl]triazole;1-tert-butyl-4-pyrrolidin-2-ylimidazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-pyrrolidin-2-yltriazole;N-methyl-1-(2-methyl-1-propan-2-ylimidazol-4-yl)methanamine;N-methyl-1-(3-propan-2-yl-1,2-oxazol-5-yl)methanamine;N-methyl-1-(1-propan-2-yltriazol-4-yl)methanamine;N-methyl-1-[1-propan-2-yl-2-(trifluoromethyl)imidazol-4-yl]methanamine;4-[(2S)-1-methylpyrrolidin-2-yl]-1-propan-2-yltriazole;1-propan-2-yl-4-[(2R)-pyrrolidin-2-yl]triazole;1-propan-2-yl-4-[(2S)-pyrrolidin-2-yl]triazole |
|---|---|
| PubChem CID | 157064007 |
| Molecular Formula | C126H224F3N45O |
| Molecular Weight | 2442.49 g/mol |
| Exact Mass | 2440.88 |
| IUPAC Name | 1-tert-butyl-4-(1-methylpyrrolidin-2-yl)triazole;1-tert-butyl-4-[(2R)-1-methylpyrrolidin-2-yl]triazole;1-tert-butyl-4-pyrrolidin-2-ylimidazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]imidazole;1-tert-butyl-4-pyrrolidin-2-yltriazole;N-methyl-1-(2-methyl-1-propan-2-ylimidazol-4-yl)methanamine;N-methyl-1-(3-propan-2-yl-1,2-oxazol-5-yl)methanamine;N-methyl-1-(1-propan-2-yltriazol-4-yl)methanamine;N-methyl-1-[1-propan-2-yl-2-(trifluoromethyl)imidazol-4-yl]methanamine;4-[(2S)-1-methylpyrrolidin-2-yl]-1-propan-2-yltriazole;1-propan-2-yl-4-[(2R)-pyrrolidin-2-yl]triazole;1-propan-2-yl-4-[(2S)-pyrrolidin-2-yl]triazole |
| SMILES | CC(C)(C)n1cc(C2CCCN2)nn1.CC(C)(C)n1cnc(C2CCCN2)c1.CC(C)(C)n1cnc([C@@H]2CCCN2)c1.CC(C)(C)n1cnc([C@H]2CCCN2)c1.CC(C)n1cc([C@@H]2CCCN2)nn1.CC(C)n1cc([C@@H]2CCCN2C)nn1.CC(C)n1cc([C@H]2CCCN2)nn1.CN1CCCC1c1cn(C(C)(C)C)nn1.CN1CCC[C@@H]1c1cn(C(C)(C)C)nn1.CNCc1cc(C(C)C)no1.CNCc1cn(C(C)C)c(C(F)(F)F)n1.CNCc1cn(C(C)C)c(C)n1.CNCc1cn(C(C)C)nn1 |
| InChI | InChI=1S/2C11H20N4.3C11H19N3.2C10H18N4.C9H14F3N3.2C9H16N4.C9H17N3.C8H14N2O.C7H14N4/c2*1-11(2,3)15-8-9(12-13-15)10-6-5-7-14(10)4;3*1-11(2,3)14-7-10(13-8-14)9-5-4-6-12-9;1-10(2,3)14-7-9(12-13-14)8-5-4-6-11-8;1-8(2)14-7-9(11-12-14)10-5-4-6-13(10)3;1-6(2)15-5-7(4-13-3)14-8(15)9(10,11)12;2*1-7(2)13-6-9(11-12-13)8-4-3-5-10-8;1-7(2)12-6-9(5-10-4)11-8(12)3;1-6(2)8-4-7(5-9-3)11-10-8;1-6(2)11-5-7(4-8-3)9-10-11/h2*8,10H,5-7H2,1-4H3;3*7-9,12H,4-6H2,1-3H3;7-8,11H,4-6H2,1-3H3;7-8,10H,4-6H2,1-3H3;5-6,13H,4H2,1-3H3;2*6-8,10H,3-5H2,1-2H3;6-7,10H,5H2,1-4H3;4,6,9H,5H2,1-3H3;5-6,8H,4H2,1-3H3/t10-;;2*9-;;;10-;;2*8-;;;/m1.10..0.10.../s1 |
| InChIKey | ABQUFMOOGZSELH-XQWOSTOISA-N |
| XLogP | 21.23 |
| TPSA | 460.12 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 46 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 175 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2442.49 |
| LogP ≤ 5 | 21.23 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 46 |